Evotec Links Up With Secarna On Cutting-Edge Antisense Technology

First Program Already Underway

Evotec has gained access to next-generation antisense technology through forging a strategic partnership with the small German biotech, Secarna, and they aim to make available a joint antisense pipeline of new therapeutic options for industry partners.    

Strategic partnership
• Source: Shutterstock

More from Deals

More from Business